These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 24515100)
21. Discontinuities and disruptions in drug dosage guidelines for the paediatric population. Chitty KM; Chan B; Pulanco CL; Luu S; Egunsola O; Buckley NA Br J Clin Pharmacol; 2018 May; 84(5):1029-1037. PubMed ID: 29411410 [TBL] [Abstract][Full Text] [Related]
22. Pediatric critical care pharmacodynamics. Dionne R; McManus C Crit Care Nurs Clin North Am; 1993 Jun; 5(2):367-75. PubMed ID: 8398042 [TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Albers S; Meibohm B; Mir TS; Läer S Br J Clin Pharmacol; 2008 Apr; 65(4):511-22. PubMed ID: 17995971 [TBL] [Abstract][Full Text] [Related]
24. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
25. Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs. Carasco CF; Fletcher P; Maconochie I Br J Clin Pharmacol; 2016 May; 81(5):849-56. PubMed ID: 26714256 [TBL] [Abstract][Full Text] [Related]
26. Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants. Tegenge MA; Mahmood I; Jiang Z; Forshee R J Clin Pharmacol; 2018 Jul; 58(7):877-884. PubMed ID: 29489016 [TBL] [Abstract][Full Text] [Related]
27. A mechanistic approach for the scaling of clearance in children. Edginton AN; Schmitt W; Voith B; Willmann S Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850 [TBL] [Abstract][Full Text] [Related]
28. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance. Mahmood I; Tegenge MA Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936 [TBL] [Abstract][Full Text] [Related]
29. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related]
30. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. McLeay SC; Morrish GA; Kirkpatrick CM; Green B Clin Pharmacokinet; 2012 May; 51(5):319-30. PubMed ID: 22439649 [TBL] [Abstract][Full Text] [Related]
31. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach. Mahmood I Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778 [TBL] [Abstract][Full Text] [Related]
32. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults. Tegenge MA; Mahmood I Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085 [TBL] [Abstract][Full Text] [Related]
33. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics. Elmorsi Y; Barber J; Rostami-Hodjegan A Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821 [TBL] [Abstract][Full Text] [Related]
34. Modelling approaches to dose estimation in children. Johnson TN Br J Clin Pharmacol; 2005 Jun; 59(6):663-9. PubMed ID: 15948929 [TBL] [Abstract][Full Text] [Related]
35. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban. Willmann S; Becker C; Burghaus R; Coboeken K; Edginton A; Lippert J; Siegmund HU; Thelen K; Mück W Clin Pharmacokinet; 2014 Jan; 53(1):89-102. PubMed ID: 23912563 [TBL] [Abstract][Full Text] [Related]
36. Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model. Vogt W Clin Pharmacokinet; 2014 Jan; 53(1):51-72. PubMed ID: 23839530 [TBL] [Abstract][Full Text] [Related]
37. Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessment. Peigné S; Bouzom F; Brendel K; Gesson C; Fouliard S; Chenel M J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):13-27. PubMed ID: 26563503 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model? Mahmood I Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504 [TBL] [Abstract][Full Text] [Related]
39. Optimizing pediatric dosing: a developmental pharmacologic approach. Anderson GD; Lynn AM Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420 [TBL] [Abstract][Full Text] [Related]
40. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pai MP Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]